Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab von Vera Dufner, Cyrus M. Sayehli, Manik Chatterjee, Horst D. Hummel, Götz Gelbrich, Ralf C. Bargou, Maria-Elisabeth Goebeler

Volltext

The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma von Manik Chatterjee, Mindaugas Andrulis, Thorsten Stühmer, Elisabeth Müller, Claudia Hofmann, Torsten Steinbrunn, Tanja Heimberger, Heike Schraud, Stefanie Kressmann, Hermann Einsele, Ralf C. Bargou

Volltext

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS von Marcel Seibold, Thorsten Stühmer, Nadine Kremer, Anja Mottok, Claus-Jürgen Scholz, Andreas Schlosser, Ellen Leich, Ulrike Holzgrabe, Daniela Brünnert, Santiago Barrio, K. Martin Kortüm, Antonio G. Solimando, Manik Chatterjee, Hermann Einsele, Andreas Rosenwald, Ralf C. Bargou, Torsten Steinbrunn

Volltext

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia von Nicola Gökbuget, Hagop M. Kantarjian, Monika Brüggemann, Anthony S. Stein, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard Heffner, Françoise Rigal-Huguet, Mark Litzow, Susan O'Brien, Gerhard Zugmaier, Shan Gao, Dirk Nagorsen, Stephen J. Forman, Max S. Topp

Volltext